Permanent vision loss resulting from relapsing ocular inflammation occurs frequently in patients with Behçet's disease, despite intensive and chronic immunosuppressive therapy. The authors report the case of a 35-year-old man with chronic bilateral posterior uveitis refractory to corticosteroids and immunosuppressive agents (methotrexate and cyclosporine) with a beneficial effect from treatment with infliximab.
tumor necrosis factor; Behçet syndrome; posterior uveitis